- Home
- SSY vs APM Comparison
SSY vs APM Comparison
Compare SSY & APM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SSY
- APM
- Stock Information
- Founded
- SSY 1959
- APM 2010
- Country
- SSY United States
- APM United Kingdom
- Employees
- SSY N/A
- APM N/A
- Industry
- SSY Hospital/Nursing Management
- APM Biotechnology: Pharmaceutical Preparations
- Sector
- SSY Health Care
- APM Health Care
- Exchange
- SSY Nasdaq
- APM Nasdaq
- Market Cap
- SSY 6.2M
- APM 6.7M
- IPO Year
- SSY N/A
- APM 2018
- Fundamental
- Price
- SSY $0.97
- APM $0.94
- Analyst Decision
- SSY
- APM
- Analyst Count
- SSY 0
- APM 0
- Target Price
- SSY N/A
- APM N/A
- AVG Volume (30 Days)
- SSY 88.5K
- APM 34.1K
- Earning Date
- SSY 05-13-2025
- APM 07-22-2025
- Dividend Yield
- SSY N/A
- APM N/A
- EPS Growth
- SSY N/A
- APM N/A
- EPS
- SSY 0.25
- APM N/A
- Revenue
- SSY $31,094,000.00
- APM N/A
- Revenue This Year
- SSY N/A
- APM N/A
- Revenue Next Year
- SSY N/A
- APM N/A
- P/E Ratio
- SSY $4.08
- APM N/A
- Revenue Growth
- SSY N/A
- APM N/A
- 52 Week Low
- SSY $0.62
- APM $0.46
- 52 Week High
- SSY $1.91
- APM $7.49
- Technical
- Relative Strength Index (RSI)
- SSY 54.43
- APM 47.15
- Support Level
- SSY $0.87
- APM $0.86
- Resistance Level
- SSY $1.10
- APM $1.01
- Average True Range (ATR)
- SSY 0.07
- APM 0.06
- MACD
- SSY 0.01
- APM -0.01
- Stochastic Oscillator
- SSY 50.65
- APM 41.16
About SSY SunLink Health Systems Inc.
SunLink Health Systems Inc is engaged in providing retail pharmacy services. The company operates its business through segments namely the Healthcare Services segment and Pharmacy segment. The Healthcare Services segment includes subsidiaries that own and operate licensed-bed, acute care hospitals, which includes bed geriatric psychology unit, and nursing home; own medical buildings, which are leased to unaffiliated healthcare providers, and adjacent vacant land; and provides information technology to outside customers. The Pharmacy segment, which is the key revenue generator is composed of retail pharmacy products and services that are conducted in rural markets; institutional pharmacy services; pharmacy services; and durable medical equipment.
About APM Aptorum Group Limited
Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in one segment: research and development. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.